UAE Genome Editing Market Size & Outlook, 2024-2030
UAE genome editing market, 2018-2030 (US$M)
Related Markets
UAE genome editing market highlights
- The UAE genome editing market generated a revenue of USD 63.6 million in 2023 and is expected to reach USD 166.6 million by 2030.
- The UAE market is expected to grow at a CAGR of 14.8% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 63.6 million |
| Market revenue in 2030 | USD 166.6 million |
| Growth rate | 14.8% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, UAE accounted for 0.8% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia genome editing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 166.6 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 46.07% in 2024. Horizon Databook has segmented the UAE genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE genome editing market is influenced by various factors. Initially, significant government funding in R&D stimulated innovation and attracted skilled professionals to the biotechnology sector in the country. Furthermore, a thriving healthcare sector and a dedication to personalized medicine propel the demand for cutting-edge genetic therapies and diagnostics.
Collaboration among academia, industry, and government is instrumental in facilitating the exchange of knowledge & technology transfer, creating an environment conducive to genetic research and advancement.
Moreover, the UAE's ambition to establish itself as a global center for biotechnology and life sciences serves as a catalyst for further market expansion. With its supportive infrastructure and ambitious goals, the UAE is expected to witness notable progress in the genome editing market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE genome editing market size, by technology, 2018-2030 (US$M)
UAE Genome Editing Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
